The optimism on the new vaccine division, which hinges solely on the Sinovac vaccine, looks uncertain and makes earnings forecasts difficult.
PETALING JAYA: Earnings visibility appears murky beyond 2021 for Pharmaniaga Bhd
as it has yet to get an extension for its medical supply contract from the government which expires by year-end.
Pharmaniaga is the largest listed pharmaceutical company in the country by revenue with the government’s drug and medical supply concession in-hand.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
